logo

 

March 2020

Volume 125, Issue 3 Pages i – v, 333-476

 If you are a BAUS member, you can log in here for full access to journal content.

     
     
     
    

 

 

The following BJUI Articles of the Week, selected by the Editor, are available for FREE until 30 April 2020.

ARTICLE OF THE MONTH:

Guideline of guidelines: social media in urology

Jacob Taylor, Stacy Loeb

First Published: 20 October 2019


Using spatial tracking with magnetic resonance imaging/ultrasound‐guided biopsy to identify unilateral prostate cancer

Steve R. Zhou, Alan M. Priester, Rajiv Jayadevan, David C. Johnson, Jason J. Yang, Jorge Ballon, Shyam Natarajan and Leonard S. Marks

First Published: 04 November 2019


External validation of novel magnetic resonance imaging‐based models for prostate cancer prediction

Lukas Püllen, Jan P. Radtke, Manuel Wiesenfarth, Monique J. Roobol, Jan F.M. Verbeek, Axel Wetter, Nika Guberina, Abhishek Pandey, Clemens Hüttenbrink, Stephan Tschirdewahn, Sascha Pahernik, Boris A. Hadaschik and Florian A. Distle

First Published: 23 November 2019


The risk of developing cardiovascular disease is increased for patients with prostate cancer who are pharmaceutically treated for depression

Barbara M. Wollersheim, Annelies H. Boekhout, Henk G. van der Poel, Lonneke V. van de Poll-Franse and Dounya Schoormans

Open Access. First Published: 26 November 2019


 

BJUI March 2020

 

EDITORIAL

Can artificial intelligence optimize case selection for hemi‐gland ablation?

Jeremy Yuen-Chun Teoh, Edmund Chiong, and Chi-Fai Ng

First Published: 18 February 2020

 

EDITOR’S CHOICE

Magnetic resonance imaging as a personalised tool to safely avoid prostate biopsy

Zachary A. Glaser, and Soroush Rais-Bahrami

First Published: 18 February 2020

A contemporary view on the use of slings and artificial urinary sphincters for the treatment of post‐prostatectomy incontinence in England

Christopher R. Chapple

First Published: 18 February 2020

 

COMMENTS

Men’s health: a novel role for the urologist on the global health stage

Lucshman Raveendran, Adam Bobrowski and Rajiv K. Singa

First published:12 October 2019

Genetic correlates of prostate cancer visibility (and invisibility) on multiparametric magnetic resonance imaging: it’s time to take stock

Joseph M. Norris, Benjamin S. Simpson, Marina A. Parry, Veeru Kasivisvanathan, Clare Allen, Rhys Ball, Alex Freeman, Daniel Kelly, Alex Kirkham, Hayley C. Whitaker and Mark Emberton

First Published: 10 October 2019

Novel agents for metastatic hormone‐sensitive prostate cancer – a practice guide for urologists

Isaac A. Thangasamy, Edmond M. Kwan, Jiasian Teh, Niranjan Sathianathen, Omar Alghazo, Shankar Siva, Arun Azad and Declan G. Murphy

First Published: 29 October 2019  

 

GUIDELINE

Guideline of guidelines: social media in urology

Jacob Taylor, Stacy Loeb

First Published: 20 October 2019

 

REVIEWS

Active surveillance in intermediate‐risk prostate cancer

Laurence Klotz

First Published: 24 October 2019

Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: a systematic review and meta‐analysis

Joost M. Blok, Ilse Pluim, Gedske Daugaard, Thomas Wagner, Katarzyna Jóźwiak, Erica A. Wilthagen, Leendert H.J. Looijenga, Richard P. Meijer, J.L.H. Ruud Bosch and Simon Horenblas

First Published: 04 December 2019

Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment

Alexandar Blazevski, Matthijs J. Scheltema, Amer Amin, James E. Thompson, Nathan Lawrentschuk and Phillip D. Stricker  

First Published: 14 November 2019

 

TRIAL – UROLOGICAL ONCOLOGY

Hemi‐ablative low‐dose‐rate prostate brachytherapy for unilateral localised prostate cancer

Stephen Langley, Jennifer Uribe, Santiago Uribe-Lewis , Adrian Franklin, Carla Perna, Alex Horton, Melanie Cunningham, Donna Higgins, Claire Deering, Sara Khaksar and Robert Laing

First Published: 09 November 2019

Added value of diffusion‐weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial

David Eldred-Evans, Joana B. Neves, Lucy A.M. Simmons, Abi Kanthabalan, Neil McCartan, Taimur T. Shah, Manit Arya, Susan C. Charman, Alex Freeman, Caroline M. Moore, Shonit Punwani, Mark Emberton and Hashim U. Ahmed

First Published: 16 November 2019

 

UROLOGICAL ONCOLOGY

Using spatial tracking with magnetic resonance imaging/ultrasound‐guided biopsy to identify unilateral prostate cancer

Steve R. Zhou, Alan M. Priester, Rajiv Jayadevan, David C. Johnson, Jason J. Yang, Jorge Ballon, Shyam Natarajan and Leonard S. Marks

First Published: 04 November 2019

External validation of novel magnetic resonance imaging‐based models for prostate cancer prediction

Lukas Püllen, Jan P. Radtke, Manuel Wiesenfarth, Monique J. Roobol, Jan F.M. Verbeek, Axel Wetter, Nika Guberina, Abhishek Pandey, Clemens Hüttenbrink, Stephan Tschirdewahn, Sascha Pahernik, Boris A. Hadaschik and Florian A. Distle

First Published: 23 November 2019

Stereotactic radiotherapy for prostate bed recurrence after prostatectomy, a multicentric series

Giulio Francolini, Barbara Alicja Jereczek-Fossa, Vanessa Di Cataldo, Gabriele Simontacchi, Giulia Marvaso, Maria Alessia Zerella, Piercarlo Gentile, Federico Bianciardi, Sara Allegretta, Beatrice Detti, Laura Masi, Monica lo Russo and Lorenzo Livi

First Published: 13 October 2019

Effect of a prospective opioid reduction intervention on opioid prescribing and use after radical prostatectomy: results of the Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic Surgery (ORIOLES) Initiative

Hiten D. Patel, Farzana A. Faisal, Neil D. Patel, Christian P. Pavlovich, Mohamad E. Allaf, Misop Han and Amin S. Herati

First Published: 23 October 2019

The risk of developing cardiovascular disease is increased for patients with prostate cancer who are pharmaceutically treated for depression

Barbara M. Wollersheim, Annelies H. Boekhout, Henk G. van der Poel, Lonneke V. van de Poll-Franse and Dounya Schoormans

Open Access. First Published: 26 November 2019

 

ROBOTICS AND LAPAROSCOPY

Do patients with Stage 3–5 chronic kidney disease benefit from ischaemia‐sparing techniques during partial nephrectomy?

Alp Tuna Beksac, Kennedy E. Okhawere, Daniel C. Rosen, Amr Elbakry, Bheesham D. Dayal, Jorge Daza, John P. Sfakianos, Abaza Ronney, Daniel D. Eun, Akshay Bhandari, Ashok K. Hemal, James Porter, Michael D. Stifelman and Ketan K. Badani

First Published: 22 November 2019 

 

UPPER URINARY TRACT

Does working channel position influence the effectiveness of flexible ureteroscopy? Results from an in vitro study

Luca Villa, Eugenio Ventimiglia, Silvia Proietti, Guido Giusti, Alberto Briganti, Andrea Salonia, Francesco Montorsi, Steeve Doizi and Olivier Traxer

First Published: 14 October 2019

Cost analysis of ureteroscopy (URS) vs extracorporeal shockwave lithotripsy (ESWL) in the management of ureteric stones <10 mm in adults: a UK perspective

Margaret Constanti, Robert C. Calvert, Kay Thomas, Andrew Dickinson and Sophie Carlisle

First Published: 30 October 2019

 

FUNCTIONAL UROLOGY

Amandeep Dosanjh, Simon Baldwin, Jemma Mytton, Dominic King, Nigel Trudgill, Mohammed Belal and Prashant Patel

First Published: 22 November 2019